Next Article in Journal
Classification of 27 Tumor-Associated Antigens by Histochemical Analysis of 36 Freshly Resected Lung Cancer Tissues
Next Article in Special Issue
Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery
Previous Article in Journal
Focal Adhesion Kinase-Dependent Role of the Soluble Form of Neurotensin Receptor-3/Sortilin in Colorectal Cancer Cell Dissociation
Previous Article in Special Issue
The Multifaceted Roles of PI3Kγ in Hypertension, Vascular Biology, and Inflammation

The Role of CC-Chemokines in the Regulation of Angiogenesis

Heart Research Institute, 7 Eliza Street, Newtown, Sydney, NSW 2042, Australia
Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia
Author to whom correspondence should be addressed.
Academic Editor: Shaker A. Mousa
Int. J. Mol. Sci. 2016, 17(11), 1856;
Received: 7 September 2016 / Revised: 2 November 2016 / Accepted: 3 November 2016 / Published: 8 November 2016
(This article belongs to the Special Issue Vascular Biology and Therapeutics)
Angiogenesis, the formation of new blood vessels, is critical for survival and in the regenerative response to tissue injury or ischemia. However, in diseases such as cancer and atherosclerosis, inflammation can cause unregulated angiogenesis leading to excessive neovascularization, which exacerbates disease. Current anti-angiogenic therapies cause complete inhibition of both inflammatory and ischemia driven angiogenesis causing a range of side effects in patients. Specific inhibition of inflammation-driven angiogenesis would therefore be immensely valuable. Increasing evidence suggests that the CC-chemokine class promotes inflammation-driven angiogenesis, whilst there is little evidence for a role in ischemia-mediated angiogenesis. The differential regulation of angiogenesis by CC-chemokines suggests it may provide an alternate strategy to treat angiogenesis associated pathological diseases. The focus of this review is to highlight the significant role of the CC-chemokine class in inflammation, versus ischemia driven angiogenesis, and to discuss the related pathologies including atherosclerosis, cancer, and rheumatoid arthritis. We examine the pros and cons of anti-angiogenic therapies currently in clinical trials. We also reveal novel therapeutic strategies that cause broad-spectrum inhibition of the CC-chemokine class that may have future potential for the specific inhibition of inflammatory angiogenesis. View Full-Text
Keywords: angiogenesis; chemokines; inflammation; ischemia angiogenesis; chemokines; inflammation; ischemia
Show Figures

Graphical abstract

MDPI and ACS Style

Ridiandries, A.; Tan, J.T.M.; Bursill, C.A. The Role of CC-Chemokines in the Regulation of Angiogenesis. Int. J. Mol. Sci. 2016, 17, 1856.

AMA Style

Ridiandries A, Tan JTM, Bursill CA. The Role of CC-Chemokines in the Regulation of Angiogenesis. International Journal of Molecular Sciences. 2016; 17(11):1856.

Chicago/Turabian Style

Ridiandries, Anisyah, Joanne T.M. Tan, and Christina A. Bursill. 2016. "The Role of CC-Chemokines in the Regulation of Angiogenesis" International Journal of Molecular Sciences 17, no. 11: 1856.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop